Smaller boost volumes associated with fewer vertebral fractures after spine SBRT
In 260 vertebral metastases, GTV-based boosts showed lower Kaplan–Meier fracture estimates than segment-based boosts, but competing-risk analyses were inconclusive.
In 260 vertebral metastases, GTV-based boosts showed lower Kaplan–Meier fracture estimates than segment-based boosts, but competing-risk analyses were inconclusive.
In 801 node-positive breast cancer patients, three-week comprehensive regional nodal IMRT showed similar overall acute toxicity and less grade ≥2 dermatitis.
Interviews with nine radiotherapy patients identified technical accuracy, professional competence, communication, and continuity of care as key elements of perceived safety.
A randomized study found no significant physical or mental quality-of-life improvement with weekly mobile symptom reporting during chemoradiotherapy.
In 32 head and neck cancer patients, taste dysfunction increased nonlinearly with cumulative tongue mucosal dose, without a validated 20-Gy threshold.
In 414 lung cancer patients, deep-learning dose features modestly improved external prediction estimates, but discrimination gains were not statistically significant.
Among 285 head and neck cancer patients, 28.4% had another primary cancer, leading to treatment modifications in 37% of affected patients.
In 473 pancreatic cancer patients, SBRT achieved 82% one-year local control, with higher biologically effective dose associated with better response.
Among 63,261 nonsurgical pancreatic cancer patients, chemotherapy plus RT was associated with longer survival, although the apparent benefit diminished over time.
In 661 node-positive oral cavity cancer patients, lymph node ratio ≥0.10 independently predicted worse survival, with the highest risk when extranodal extension coexisted.
In 55 patients with locally advanced rectal cancer, bowel-sparing IMRT achieved 7.3% grade ≥2 acute diarrhea against a 26% historical benchmark.
Among 76 children aged three years or younger, proton therapy achieved 85.2% two-year local control, with 14.9% severe late toxicity.
In SRAM, weekly pelvic SBRT produced similar grade ≥2 toxicity but worse bowel quality-of-life scores at 9 and 12 months versus IMRT.
ROADS phase III found 1.3% versus 15.4% surgical bed recurrence at 12 months with cesium-131 tiles versus postoperative stereotactic RT.
In 71 matched pairs with esophageal squamous cell carcinoma, postoperative RT was associated with 91.0% versus 75.5% two-year overall survival.